IL6 and arthritic joint disease: Nevertheless, the trend to reduced IL-6 in animals treated with n3-PUFA, the synbiotic, and ldTofa+Syn is in accordance with work from Morin and colleagues, finding a significant reduction in systemic IL-6 in a model of arthritis upon supplementation with purified EPA (64).